secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2024-01-12T23:59:59+00:00
Accession:  0001193125-24-007640
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus accelerates vesting of former Interim CEO Bihl's equity awards upon CEO transition
--------------------------------------------------------------------------------

- Board accelerated all outstanding and unvested equity awards of Anthony P. Bihl III effective January 9, 2024.
- Equity awards were originally set to vest in April 2024; acceleration was discretionary under award terms.
- Bihl served as Interim President and CEO since April 2023; Robert E. Claypoole succeeded him on January 10, 2024.
- Acceleration based on Bihl's performance and contributions to the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000119312524007640/0001193125-24-007640-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000119312524007640/d727616d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-007640

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer